Impact of a Low-Carbohydrate Diet in Pediatric Type 1 Diabetes

Condition:   Type 1 Diabetes Intervention:   Other: Dietary Intervention Sponsor:   Vanderbilt University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

Conditions:   Diabetes Mellitus, Type 1;   Diabetes Mellitus Interventions:   Drug: Lantus Solostar, 100 Units/mL Subcutaneous Solution;   Drug: Insulin RinGlar, 100 Units/mL Subcutaneous Solution Sponsor:   Geropharm Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
ConclusionsThese results confirm that a gap exists between patients ’ knowledge and expectations on retinopathy and providers’ expertise and assumptions. To bridge this gap, patient-centered education and engaging approaches may be more effective than simple information given during consultations.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
Conclusion: In conclusion, this study demonstrates that the influence of chronic diseases (bronchial asthma, diabetes mellitus type 1 and hypothyroidism) on olfactory function in childhood, if any, seems to be insignificant. This is partly in contrast to adult patients. Further research should be conducted in a subgroup of patients with bronchial asthma, allergic rhinitis, and atopic dermatitis or other comorbidities to better understand the association of allergic diathesis and olfactory function and the putative pathogenesis of olfactory dysfunction.What is known:• The association between smell impairment and chroni...
Source: European Journal of Pediatrics - Category: Pediatrics Source Type: research
Unfortunately there is a mistake in the presentation of the affiliations in this paper.
Source: Diabetologia - Category: Endocrinology Source Type: research
Conclusions/interpretationMaternal obesity is associated with increased incidence of type 2 diabetes in the offspring. Evidence-based strategies that reduce obesity among women of reproductive age and that might reduce the incidence of diabetes in their offspring are urgently required.
Source: Diabetologia - Category: Endocrinology Source Type: research
We described a 9-month boy who was admitted to our hospital because of severe pneumonia and developed DRESS 3 weeks later. In addition, we performed a literature review of diabetes mellitus associated with DRESS by searching the PubMed. A total of 16 articles and 27 related case reports were obtained between 2001 and 2018. The mean age was 46yr. The duration from the onset of DRESS to the development of DM was 21d on average. 21 patients were diagnosed F1TD, 5 patients were confirmed T1DM, and 1 patient was defined T2DM. GAD were detected in 4 cases. Of 22 cases in which virus examination were carried out, evidence of viru...
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
Innovative devices have streamlined diabetes management. Here are just a few of the new gadgets that have made life easier for people with type 1 and type 2 diabetes.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Conclusion: ART-naive Ethiopian HIV patients had a high prevalence of prediabetes and diabetes, with a poor agreement between HbA1c and OGTT. Diabetes was associated with inflammation, but not with adiposity and age. Diabetes was linked to insulin deficiency, rather than insulin resistance, which may represent a different entity than type 1 and 2 diabetes. This has implications for choice of drugs, when managing diabetes in African HIV patients.
Source: AIDS - Category: Infectious Diseases Tags: CLINICAL SCIENCE Source Type: research
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a supplement to insulin in adults with a rare-type of the condition.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Carbohydrates | Diabetes | Diabetes Type 1 | Diets | Endocrinology | Nutrition | Pediatrics | Research